Publications by authors named "E Cale"

Claim this Profile
A
A multidonor class of highly glycan-dependent HIV-1 gp120-gp41 interface-targeting broadly neutralizing antibodies.
Evan M Cale, Chen-Hsiang Shen, Adam S Olia, Nathan A Radakovich, Reda Rawi

Cell Rep· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of B cell immortalization for the isolation of antibodies and B cell clones from vaccine and infection settings.
Kristin L Boswell, Timothy A Watkins, Evan M Cale, Jakob Samsel, Sarah F Andrews

Front Immunol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and tolerability of AAV8 delivery of a broadly neutralizing antibody in adults living with HIV: a phase 1, dose-escalation trial.
Joseph P Casazza, Evan M Cale, Sandeep Narpala, Galina V Yamshchikov, Emily E Coates

Nat Med· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antigenic analysis of the HIV-1 envelope trimer implies small differences between structural states 1 and 2.
Evan M Cale, Jefferson I Driscoll, Myungjin Lee, Jason Gorman, Tongqing Zhou

J Biol Chem· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engineering well-expressed, V2-immunofocusing HIV-1 envelope glycoprotein membrane trimers for use in heterologous prime-boost vaccine regimens.
Emma T Crooks, Francisco Almanza, Alessio D'Addabbo, Erika Duggan, Jinsong Zhang, Evan Cale

PLoS Pathog· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis